SAN DIEGO, Aug. 31, 2020 /PRNewswire/ -- Evofem
Biosciences, Inc. (NASDAQ: EVFM), a commercial-stage
biopharmaceutical company, today announced it will participate in
four healthcare equity conferences in September:
- H.C. Wainwright & Co. 22nd Annual Global Investment
Conference: presentation on
Monday, September 14, 2020 from
3:30 to 3:50 p.m. EST.
- 2020 Cantor Global Virtual Healthcare Conference: virtual
fireside chat on
Wednesday, September 16, 2020 from
4:00 p.m. to 4:30 p.m. EST.
- Morgan Stanley 18th Annual Global Healthcare Conference:
virtual fireside chat on
Friday, September 18, 2020 from
11:00 a.m. to 11:30 a.m. EST.
- Oppenheimer Fall Healthcare Life Sciences &
MedTech Summit: virtual fireside chat on
Tuesday, September 22, 2020 from
10:50 a.m. to 11:30 a.m. EST.
To access the live and archived webcasts of these presentations,
visit the Investors section of the Evofem Biosciences website
at www.evofem.com, and select the Events and Presentations
tab.
About Evofem Biosciences, Inc.
Evofem
Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage
biopharmaceutical company committed to developing and
commercializing innovative products to address unmet needs in
women's sexual and reproductive health, including hormone-free,
woman-controlled contraception and protection from certain sexually
transmitted infections (STIs). The Company's first commercial
product, Phexxi™ (lactic acid, citric acid and potassium
bitartrate), is the first and only hormone-free, prescription
vaginal gel approved in the United States for the
prevention of pregnancy. The Company is also advancing EVO100 into
Phase 3 clinical trials for the prevention of urogenital
transmission of both Chlamydia
trachomatis infection (chlamydia) and Neisseria
gonorrhoeae infection (gonorrhea) in women. For more
information, please visit www.evofem.com.
Phexxi™ is a trademark of Evofem Biosciences, Inc.
Investor Contact
Amy Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
M: (917) 673-5775
Media Contact
Becky Vonsiatsky
W2O Group
bvonsiatsky@w2ogroup.com
M: (413) 478-2003
View original content to download
multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-to-participate-in-four-upcoming-investor-conferences-301120737.html
SOURCE Evofem Biosciences, Inc.